BIOLIFE SOLUTIONS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biolife Solutions Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2011 to Q2 2024.
  • Biolife Solutions Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.46M, a 4.73% decline year-over-year.
  • Biolife Solutions Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $30.2M, a 11.7% increase year-over-year.
  • Biolife Solutions Inc annual Share-based Payment Arrangement, Expense for 2023 was $31.7M, a 25% increase from 2022.
  • Biolife Solutions Inc annual Share-based Payment Arrangement, Expense for 2022 was $25.3M, a 81.5% increase from 2021.
  • Biolife Solutions Inc annual Share-based Payment Arrangement, Expense for 2021 was $14M, a 133% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $30.2M $5.46M -$271K -4.73% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $30.5M $6.18M -$1.18M -16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $31.7M $9.46M +$1.8M +23.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $29.9M $9.12M +$2.82M +44.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $27.1M $5.73M -$241K -4.04% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $27.3M $7.36M +$1.96M +36.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $25.3M $7.66M +$3.62M +89.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $21.7M $6.3M +$1.43M +29.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $20.3M $5.97M +$3.45M +137% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $16.8M $5.4M +$2.88M +114% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $14M $4.05M +$1.89M +87.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $12.1M $4.87M +$3.31M +212% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $8.76M $2.52M +$1.38M +120% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $7.39M $2.52M +$1.41M +126% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-09
Q4 2020 $5.98M $2.16M +$1.3M +150% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $4.68M $1.56M +$731K +88.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $3.95M $1.15M +$327K +40% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $3.63M $1.11M +$582K +110% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $3.04M $865K +$476K +122% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $2.57M $829K +$446K +116% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.12M $818K +$444K +119% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.68M $531K +$158K +42.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-29
Q4 2018 $1.52M $389K +$76.7K +24.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-15
Q3 2018 $1.44M $383K +$69.1K +22% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.37M $374K +$60.1K +19.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.31M $373K +$43.1K +13.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.27M $312K +$119K +61.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $1.15M $314K +$133K +73.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.02M $314K +$57.6K +22.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $960K $330K +$183K +125% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $777K $193K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $181K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $256K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $147K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q3 2012 $57.1K +$5.35K +10.3% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-13
Q3 2011 $51.8K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.